Sharda Cropchem Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
SHARDACROP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.6 pts more than Nifty Microcap 250 and 0.1 pts less than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Sharda Cropchem reported consolidated revenue from operations of ₹98,481 lakhs for Q1 FY26, up about 25% from ₹78,511 lakhs in Q1 FY25, driven by both Agrochemicals (₹84,624 lakhs, up ~25%) and Non-agrochemicals (₹13,858 lakhs, up ~31%) segments. Net profit jumped sharply to ₹14,280 lakhs from ₹2,725 lakhs in the year-ago quarter, with EPS rising to ₹15.83 from ₹3.02. The big profit lift was supported by a strong foreign exchange gain of ₹7,309 lakhs (versus an FX loss of ₹831 lakhs last year), lower inventory-related costs, and operating leverage. The board cleared the results on July 25, 2025, and auditor B S R & Co. LLP issued an unmodified limited review conclusion on both standalone and consolidated numbers. The company noted that its agrochemicals business is seasonal, so quarterly results are not necessarily representative of full-year performance.
A very strong quarter with healthy top-line growth and a multi-fold jump in profits, aided significantly by forex gains, is likely to be viewed positively by investors. However, the heavy dependence on FX swings and the seasonal nature of the agrochemical business mean the headline earnings beat should be read with some caution on sustainability.